<?xml version="1.0" encoding="UTF-8" ?>
<abstract xmlns="http://eprints.org/ep2/data/2.0">Many occupational studies have inferred central nervous system dysfunction as an outcome&#13;
of toluene exposure. The sleep–wakefulness cycle is a universal model of brain integrative&#13;
activity, which reflects multiple levels of the homeostatic processes. In this study, the&#13;
structure of the sleep–wakefulness cycle of the rat, the quantitative ratio of phases, their&#13;
electrographic characteristics and changes in the content of intraventricular glutamate,&#13;
aspartate and arginine were determined in the normal state, after 10 days inhalation of&#13;
toluene, 5 days after its withdrawal and after the action of chlorogenic acid, one of the most&#13;
abundant polyphenols in the human diet with antioxidant, anticarcinogenic and&#13;
neuroprotective properties. Using electroencephalography for the determination of&#13;
behavioural state we found that toluene inhalation disrupts the normal sleep cycle, increased&#13;
the total length of wakefulness, suppressed REM sleep, and reduced non-REM sleep. We&#13;
have furthermore shown that the content of intraventricular glutamate was increased in all&#13;
states of the sleep–wakefulness cycle while the concentration of aspartate was decreased.&#13;
Arginine was diminished during wakefulness and non-REM sleep and increased in REM&#13;
sleep. Intraperitoneal administration of chlorogenic acid resulted in rapid normalization both&#13;
of the duration of the sleep–wakefulness cycle and the amino acid contents. These findings&#13;
suggest that toluene engenders disturbance of excitatory amino acid and nitric oxide&#13;
metabolism, which is reflected in the dynamics of the sleep–wakefulness cycle and duration&#13;
of its phases.&#13;
Keywords: aspartate, arginine, chlorogenic acid, glutamate, rat</abstract>
